Clinical Trial Update: Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma [Phase 1]

View source ↗

Summary

This entry reports on a Phase 1 clinical trial evaluating local modulation of immune receptors to enhance the response to dendritic cell vaccination in metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: Duke University | Conditions: Metastatic Melanoma | Phase 1 | Status: TERMINATED